Pharmacy Practice
Affordable Medicines
Biosimilars
Compliance
Compounding
Drug Approvals
Geriatrics
Hospital/Health System
In-Pharmacy Vaccines
Law
Medication Management
News & Trends
OTC
Pharmacist Resources
Specialty Pharmacy
Technology
Disease State
Allergy
Autoimmune
Breast Cancer
Cardiovascular
Cold & Flu
COVID-19
Dermatology
Diabetes
Gastroenterology
Hematology
HIV/AIDS
Infectious Disease
Infusion
Lung Cancer
Mental Health
mRNA Technology
Neurology
Oncology
Ophthalmology
Orthopedics
Pain Management
Pediatrics
Respiratory
Schizophrenia
Urology/Nephrology
Women’s Health
Health Awareness Month
Videos
Patient Teaching Aid
Publications
Featured Issue
Featured Supplements
Conference Coverage
Continuing Education
Subscribe
COVID-19 Resources
Affordable Medicines
June 16, 2022
Introduction to Two Recently Approved Insulin Glargine Biosimilars
Two insulin biosimilars for insulin glargine, a subcutaneous long-acting insulin analogue for improving glycemic control, have recently been approved
June 16, 2022
Dispelling Generic Drug Myths and Misconceptions
October 15, 2021
A Pharmacist’s Primer on Prescription Discount Cards
September 22, 2021
Pharmacy Group Supports Lower Drug Prices; Opposes More Imports
June 11, 2021
Uncovering the Impact of Storage on Generic Medications
June 11, 2021
FDA Update: Improving Access to Biosimilar Drug Products
February 3, 2021
U.S. Cost of Brand-Name Drugs More Than Triple of Many Other Countries
August 26, 2020
Changes in Generic Pill Appearance Affect Medication Adherence
July 10, 2020
Common Supplements Might Reduce COVID Severity
June 18, 2020
Discussing Brand Versus Generic Medications
June 18, 2020
Getting Up to Speed With Generic Regulations
June 18, 2020
Naming of Biological Products
June 18, 2020
Factors Involved in U.S. Generic Drug Shortages
Load More
X
May 2023
In This Issue
Digital Magazine
Archives
Subscription
×
Full Image